R1 RCM Lowers FY24 Outlook: Projects Revenues Of $2.60B-$2.64B Vs. $2.64B Estimate (Prior View: $2.625B-$2.675B); Sees Adjusted EBITDA Of $625M-$650M (Prior View: $650M-$670M)
R1 RCM Lowers FY24 Outlook: Projects Revenues Of $2.60B-$2.64B Vs. $2.64B Estimate (Prior View: $2.625B-$2.675B); Sees Adjusted EBITDA Of $625M-$650M (Prior View: $650M-$670M)
R1 RCM下调了24财年展望：预计收入为26.0亿美元至26.4亿美元，而预期为26.4亿美元（先前观点：26.25亿美元至26.75亿美元）；调整后的息税折旧摊销前利润为6.25亿至6.5亿美元（先前观点：6.5亿至6.7亿美元）
For 2024, R1 now expects to generate:
到2024年，R1现在预计将产生：
- Revenue of $2.60 billion to $2.64 billion
- GAAP operating income of $85 million to $105 million
- Adjusted EBITDA of $625 million to $650 million
- 收入为26.0亿美元至26.4亿美元
- GAAP 营业收入为 8,500 万美元至 1.05 亿美元
- 调整后的息税折旧摊销前利润为6.25亿美元至6.5亿美元
The updated guidance reflects the impacts of the Change Healthcare cyberattack on first quarter and expected full year 2024 revenue related to collections timing, claims inflows, and the ability to meet key performance metrics, as well as increased expenses to support our customers.
更新后的指导方针反映了Change Healthcare网络攻击对第一季度和2024年全年预期收入的影响，这些收入与收款时间、索赔流入、满足关键绩效指标的能力以及支持客户的支出增加有关。